Back
Regulus Therapeutics Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
30
RGLS
Regulus Therapeutics
Last Price:
$1.54
Seasonality Move:
7.82%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Regulus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.57 | Sell |
| 20-day SMA: | 1.59 | Sell |
| 50-day SMA: | 1.53 | Buy |
| 200-day SMA: | 1.89 | Sell |
| 8-day EMA: | 1.56 | Sell |
| 20-day EMA: | 1.57 | Sell |
| 50-day EMA: | 1.56 | Sell |
| 200-day EMA: | 1.67 | Sell |
Regulus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 48.29 | Sell |
| Chaikin Money Flow: | 45990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.48 - 1.64) | Sell |
| Bollinger Bands (100): | (1.47 - 1.65) | Sell |
Regulus Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regulus Therapeutics Stock
Is Regulus Therapeutics Stock a Buy?
-
Regulus Therapeutics share price is 1.54 while RGLS 8-day simple moving average is 1.57, which is a Sell signal.
-
The stock price of RGLS is 1.54 while Regulus Therapeutics 20-day SMA is 1.59, which makes it a Sell.
-
Regulus Therapeutics 50-day simple moving average is 1.53 while RGLS share price is 1.54, making it a Buy technically.
-
RGLS stock price is 1.54 and Regulus Therapeutics 200-day simple moving average is 1.89, creating a Sell signal.
RGLS Technical Analysis vs Fundamental Analysis
Sell
30
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy or a Sell?
-
Regulus Therapeutics stock is rated a SellThe current Regulus Therapeutics [RGLS] share price is $1.54. The Score for RGLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Regulus Therapeutics Stock Info
Market Cap:
100.9M
Price in USD:
1.54
Share Volume:
46K
Regulus Therapeutics 52-Week Range
52-Week High:
3.79
52-Week Low:
1.08
Sell
30
Regulus Therapeutics (RGLS)
is a Sell
Regulus Therapeutics Share Price Forecast
-
What is the Regulus Therapeutics stock price today?The Regulus Therapeutics stock price is 1.54 USD today.
-
Will RGLS stock go up or go down?Regulus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Regulus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regulus Therapeutics is overvalued.
Is Regulus Therapeutics Stock a Buy?
-
Regulus Therapeutics share price is 1.54 while RGLS 8-day exponential moving average is 1.56, which is a Sell signal.
-
The stock price of RGLS is 1.54 while Regulus Therapeutics 20-day EMA is 1.57, which makes it a Sell.
-
Regulus Therapeutics 50-day exponential moving average is 1.56 while RGLS share price is 1.54, making it a Sell technically.
-
RGLS stock price is 1.54 and Regulus Therapeutics 200-day simple moving average is 1.67, creating a Sell signal.
Fundamental Analysis of Regulus Therapeutics
Is Regulus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Regulus Therapeutics
Should I short Regulus Therapeutics stock?
-
RGLS Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Regulus Therapeutics is a Buy
-
Regulus Therapeutics Relative Strength Index (RSI) is 48.29, which suggest Regulus Therapeutics is oversold
-
The Bollinger Bands (25) for Regulus Therapeutics is (1.48 - 1.64), which suggest Regulus Therapeutics is a Sell
-
The Bollinger Bands (100) for Regulus Therapeutics is (1.47 - 1.65), which suggest Regulus Therapeutics is a Sell
* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.